Saventic Healthsp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Saventic Health is a company that utilizes AI-driven technology to streamline clinical trials, diagnostics, and treatment pathways for rare diseases. It provides tools to identify high-risk patients faster and more accurately, facilitating recruitment for clinical studies and improving patient outcomes. Additionally, Saventic Health offers integration with hospital EMRs and a global online application for patients and caregivers to manage the patient journey.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2018-12-01. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jul 5, 2024 | Call to creditors |
Public aid
14 public aid cases recorded, with a total value of $2,175,671.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 30, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $394 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Aug 8, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $696 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Aug 8, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $691 | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-05-01 | Opracowanie Innowacyjnego, wykorzystującego sztuczną inteligencję i opartego o nową wiedzę zbudowaną na dużym zbiorze rzeczywistych danych medycznych, algorytmicznego silnika wspierającego lekarzy we wcześniejszym wykrywaniu i leczeniu niedoborów żelaza na podstawie wyników morfologii krwi i innych badań diagnostycznych. | $1,017,508 | Fundusze Europejskie dla Nowoczesnej Gospodarki | |
| 2025-05-01 | Opracowanie silnika wspierającego, przy użyciu zaawansowanych metod wykorzystujących sztuczną inteligencję i zdolność maszyn do przetwarzania milionów rekordów pacjentów w miarodajnie krótkim czasie, wczesne wykrywanie ryzyka chorób reumatologicznych, a tym samym wsparcie procesu diagnostycznego wykonywanego przez lekarza. | $753,953 | Fundusze Europejskie dla Nowoczesnej Gospodarki | |
| 2020-12-01 | Opracowanie i wdrożenie innowacyjnego, opartego o uczenie maszynowe procesu diagnostycznego, w celu skrócenia ścieżki pacjenta i poprawy jakości opieki zdrowotnej nad pacjentami z chorobami limfo- i mieloproliferacyjnymi. | $344,748 | Program Operacyjny Inteligentny Rozwój |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
The following are authorised to submit declarations concerning the company's property rights and obligations and to sign on behalf of the company: A. in the case of a multi-member management board: two members of the management board acting jointly always with the President of the Management Board, if appointed, and the Vice-President of the Management Board, if appointed; B. in the case of a one-person management board: one member of the management board independently.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 132 | $1,782.82 | 15.7706% | |
Grzegorz Władysław Basak (48) | 141 | $1,904.38 | 16.8459% |
Karol Lis (39) | 111 | $1,499.19 | 13.2616% |
| 108 | $1,458.67 | 12.9032% | |
Szymon Piotr Piątkowski (46) | 225 | $3,038.90 | 26.8817% |
Others | 120 | $1,620.75 | 14.337% |
Beneficial owners
| Person | Rights |
|---|---|
Szymon Piotr Piątkowski (46)  | Shareholder of a limited liability company, 3750.0 PLN |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Sidlysp. z o.o. | $4,977,649.42 | sidly.eu | |
| MedappS.A. | $3,351,163.61 | medapp.pl | |
| Scope FluidicsS.A. | $3,082,936.61 | scopefluidics.com | |
| Clinchoicesp. z o.o. | $2,048,208.30 | clinchoice.com | |
| Medsource Polskasp. z o.o. | $1,620,329.12 | medsource.com.pl | |
| DigitmedS.A. | $382,907.91 | digitmed.pl | |
| MedisensonicS.A. | $362,572.63 | medisensonic.com | |
| BiocamS.A. | $327,799.68 | biocam.ai | |
| JAS Analyticssp. z o.o. | $245,699.54 | jasanalytics.eu | |
| Dicellasp. z o.o. | $206,073.49 | dicella.com |
Change history
| Date | Event |
|---|---|
| 2025-12-09 | Share capital change (41,550.00 PLN → 41,850.00 PLN) |
| 2025-03-17 | Share capital change (13,850.00 PLN → 41,550.00 PLN) |
| 2025-01-16 | Share capital change (13,050.00 PLN → 13,850.00 PLN) |
| 2024-10-31 | Share capital change (12,600.00 PLN → 13,050.00 PLN) |
| 2024-10-16 | Share capital change (13,550.00 PLN → 12,600.00 PLN) |
FAQ
Last updated: 2026-07-09